1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Tetraethylammonium: new trials by email Literature Review of Tetraethylammonium trials Research Report on Tetraethylammonium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Endothelial Hyperpolarization in Humans Tetraethylammonium (TEA), L-NG-monomethyl Arginine (L-NMMA), Bradykinin - Hyperlipidemia | Phase 2 | Terminated | Emory University | 174 | 2002-07-01 | 2018-08-15 |
Hyperlipidemias (1)
Emory University (1)
United States (1)
PMID 21555712, PMID 24675657, PMID 24925526, PMID 25648989
R01HL079115 (1)